Source:http://linkedlifedata.com/resource/pubmed/id/20927342
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2010-10-7
|
pubmed:abstractText |
Active targeting of a drug carrier to a specific target site is crucial to provide a safe and efficient delivery of therapeutics and imaging contrast agents. E-selectin expression is induced on the endothelial cell surface of vessels in response to inflammatory stimuli but is absent in the normal vessels. Thus, E-selectin is an attractive molecular target, and high affinity ligands for E-selectin could be powerful tools for the delivery of therapeutics and/or imaging agents to inflamed vessels. In this study, we identified a thiophosphate modified aptamer (thioaptamer, TA) against E-selectin (ESTA-1) by employing a two-step selection strategy: a recombinant protein-based TA binding selection from a combinatorial library followed by a cell-based TA binding selection using E-selectin expressing human microvascular endothelial cells. ESTA-1 selectively bound to E-selectin with nanomolar binding affinity (K(D)?= 47 nM) while exhibiting minimal cross reactivity to P- and L-selectin. Furthermore, ESTA-1 binding to E-selectin on the endothelial cells markedly antagonized the adhesion (over 75% inhibition) of sLe(x) positive HL-60 cells at nanomolar concentration. ESTA-1 also bound specifically to the inflamed tumor-associated vasculature of human carcinomas derived from breast, ovarian, and skin but not to normal organs, and this binding was highly associated with the E-selectin expression level. Similarly, intravenously injected ESTA-1 demonstrated distinct binding to the tumor vasculature in a breast cancer xenograft model. Together, our data substantiates the discovery of a thioaptamer (ESTA-1) that binds to E-selectin with high affinity and specificity, thereby highlighting the potential application of ESTA-1 for E-selectin targeted delivery.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aptamers, Nucleotide,
http://linkedlifedata.com/resource/pubmed/chemical/E-Selectin,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphates,
http://linkedlifedata.com/resource/pubmed/chemical/thiophosphoric acid
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1932-6203
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:meshHeading |
pubmed-meshheading:20927342-Animals,
pubmed-meshheading:20927342-Aptamers, Nucleotide,
pubmed-meshheading:20927342-Base Sequence,
pubmed-meshheading:20927342-Blood Circulation,
pubmed-meshheading:20927342-Drug Screening Assays, Antitumor,
pubmed-meshheading:20927342-E-Selectin,
pubmed-meshheading:20927342-Endothelial Cells,
pubmed-meshheading:20927342-HL-60 Cells,
pubmed-meshheading:20927342-Humans,
pubmed-meshheading:20927342-Kinetics,
pubmed-meshheading:20927342-Ligands,
pubmed-meshheading:20927342-Mice,
pubmed-meshheading:20927342-Molecular Sequence Data,
pubmed-meshheading:20927342-Neoplasms,
pubmed-meshheading:20927342-Nucleic Acid Conformation,
pubmed-meshheading:20927342-Phosphates,
pubmed-meshheading:20927342-Protein Binding
|
pubmed:year |
2010
|
pubmed:articleTitle |
Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting.
|
pubmed:affiliation |
Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center, Houston, Texas, United States of America.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|